ArticleInternational cancer conference journal2025
Reduction of bleeding by cabozantinib in metastatic renal cell carcinoma with hereditary hemorrhagic telangiectasia.
Satoshi Kitamura et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.